Condor Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-43,000
| Closed | -$23K | – | 190 |
|
2019
Q4 | $23K | Buy |
43,000
+29,000
| +207% | +$15.5K | ﹤0.01% | 183 |
|
2019
Q3 | $53K | Hold |
14,000
| – | – | 0.01% | 183 |
|
2019
Q2 | $93K | Buy |
+14,000
| New | +$93K | 0.01% | 184 |
|
2019
Q1 | – | Sell |
-14,000
| Closed | -$55K | – | 191 |
|
2018
Q4 | $55K | Buy |
+14,000
| New | +$55K | 0.01% | 182 |
|